These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 27109619)

  • 1. Heart Failure Therapies for End-Stage Chemotherapy-Induced Cardiomyopathy.
    Mukku RB; Fonarow GC; Watson KE; Ajijola OA; Depasquale EC; Nsair A; Baas AS; Deng MC; Yang EH
    J Card Fail; 2016 Jun; 22(6):439-48. PubMed ID: 27109619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased need for right ventricular support in patients with chemotherapy-induced cardiomyopathy undergoing mechanical circulatory support: outcomes from the INTERMACS Registry (Interagency Registry for Mechanically Assisted Circulatory Support).
    Oliveira GH; Dupont M; Naftel D; Myers SL; Yuan Y; Tang WH; Gonzalez-Stawinski G; Young JB; Taylor DO; Starling RC
    J Am Coll Cardiol; 2014 Jan; 63(3):240-8. PubMed ID: 24161324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and survival of patients with chemotherapy-induced cardiomyopathy undergoing heart transplantation.
    Oliveira GH; Hardaway BW; Kucheryavaya AY; Stehlik J; Edwards LB; Taylor DO
    J Heart Lung Transplant; 2012 Aug; 31(8):805-10. PubMed ID: 22551930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Matched Cohort Study of Patients With End-Stage Heart Failure from Anthracycline-Induced Cardiomyopathy Requiring Advanced Cardiac Support.
    Thomas GR; McDonald MA; Day J; Ross HJ; Delgado DH; Billia F; Butany JW; Rao V; Amir E; Bedard PL; Thavendiranathan P
    Am J Cardiol; 2016 Nov; 118(10):1539-1544. PubMed ID: 27639686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced Heart Failure Therapies for Cancer Therapeutics-Related Cardiac Dysfunction.
    Bianco CM; Al-Kindi SG; Oliveira GH
    Heart Fail Clin; 2017 Apr; 13(2):327-336. PubMed ID: 28279418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced heart failure therapies for patients with chemotherapy-induced cardiomyopathy.
    Oliveira GH; Qattan MY; Al-Kindi S; Park SJ
    Circ Heart Fail; 2014 Nov; 7(6):1050-8. PubMed ID: 25415958
    [No Abstract]   [Full Text] [Related]  

  • 7. Anthracycline-related cardiotoxicity in childhood cancer survivors.
    Lipshultz SE; Karnik R; Sambatakos P; Franco VI; Ross SW; Miller TL
    Curr Opin Cardiol; 2014 Jan; 29(1):103-12. PubMed ID: 24284979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-induced cardiomyopathy.
    Higgins AY; O'Halloran TD; Chang JD
    Heart Fail Rev; 2015 Nov; 20(6):721-30. PubMed ID: 26338137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic prevention of anthracycline-induced cardiomyopathy.
    Maradia K; Guglin M
    Cardiol Rev; 2009; 17(5):243-52. PubMed ID: 19690476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure.
    Araujo-Gutierrez R; Ibarra-Cortez SH; Estep JD; Bhimaraj A; Guha A; Hussain I; Park MH; Torre-Amione G; Trachtenberg BH
    Cardiooncology; 2018; 4():3. PubMed ID: 32154004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced heart failure due to cancer therapy.
    Shah S; Nohria A
    Curr Cardiol Rep; 2015; 17(4):16. PubMed ID: 25687365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular assist devices in patients with chemotherapy-induced cardiomyopathy: new modalities.
    Sayin OA; Ozpeker C; Schoenbrodt M; Oz F; Borgermann J; Gummert J; Morshuis M
    Acta Cardiol; 2015 Aug; 70(4):430-4. PubMed ID: 26455245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ventricular assist device implantation as a bridge to cardiac transplantation in two adolescents with end-stage cardiomyopathy and heart failure as a result of anthracycline use].
    Berends M; van Bokhoven MM; van de Luijtgaarden A; Bellersen LB; van Hoesel QC; van Herpen CM
    Ned Tijdschr Geneeskd; 2008 Sep; 152(38):2088-92. PubMed ID: 18837186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to anthracyclines during childhood causes cardiac injury.
    Lipshultz SE
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orthotopic Heart Transplantation and Mechanical Circulatory Support in Cancer Survivors: Challenges and Outcomes.
    Ghosh N; Hilton J
    J Oncol; 2015; 2015():232607. PubMed ID: 26339241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left Ventricular Dysfunction and Chemotherapeutic Agents.
    Clasen SC; Wald JW
    Curr Cardiol Rep; 2018 Mar; 20(4):20. PubMed ID: 29520629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of end-stage LV dysfunction: has it improved from the classic Franciosa and Cohn Graph?
    Jacoby D; Albajrami O; Bellumkonda L
    Cardiol Clin; 2011 Nov; 29(4):485-95. PubMed ID: 22062195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anthracycline-induced cardiomyopathy].
    Roul G; Cohen C; Lieber A
    Presse Med; 2009 Jun; 38(6):987-94. PubMed ID: 19423276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Cancer Therapeutics-Related Cardiac Dysfunction.
    Vallakati A; Konda B; Lenihan DJ; Baliga RR
    Heart Fail Clin; 2018 Oct; 14(4):553-567. PubMed ID: 30266364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.